Ładuje się......
Mirabegron, a breakthrough in overactive bladder syndrome?
Objective: Overactive bladder syndrome is a condition with high prevalence, which has a negative impact on patients’ quality of life. A drug with a novel mechanism of action has been recently approved: mirabegron. The objective of this study is to review the scientific evidence available on mirabeg...
Zapisane w:
| Wydane w: | Farmacia Hospitalaria |
|---|---|
| Główni autorzy: | , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Sociedad Española de Farmacia Hospitalaria
2017
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.redalyc.org/articulo.oa?id=365962304009 https://www.redalyc.org/journal/3659/365962304009/ https://www.redalyc.org/journal/3659/365962304009/html/ https://www.redalyc.org/journal/3659/365962304009/365962304009.epub https://www.redalyc.org/journal/3659/365962304009/movil |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|